Cargando…

CRISPR-Cas systems for diagnosing infectious diseases

Infectious diseases are a global health problem affecting billions of people. Developing rapid and sensitive diagnostic tools is key for successful patient management and curbing disease spread. Currently available diagnostics are very specific and sensitive but time-consuming and require expensive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kostyusheva, Anastasiya, Brezgin, Sergey, Babin, Yurii, Vasilyeva, Irina, Glebe, Dieter, Kostyushev, Dmitry, Chulanov, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032595/ https://www.ncbi.nlm.nih.gov/pubmed/33839288 http://dx.doi.org/10.1016/j.ymeth.2021.04.007

Ejemplares similares

Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas Systems
por: Brezgin, Sergey, et al.
Publicado: (2021)

Dead Cas Systems: Types, Principles, and Applications
por: Brezgin, Sergey, et al.
Publicado: (2019)

Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification
por: Kostyusheva, Anastasiya, et al.
Publicado: (2021)

Suppressing the NHEJ pathway by DNA-PKcs inhibitor NU7026 prevents degradation of HBV cccDNA cleaved by CRISPR/Cas9
por: Kostyushev, Dmitry, et al.
Publicado: (2019)

Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing Cure
por: Kostyusheva, Anastasiya, et al.
Publicado: (2018)

CRISPR Screening: Molecular Tools for Studying Virus–Host Interactions
por: Chulanov, Vladimir, et al.
Publicado: (2021)

Gene Editing by Extracellular Vesicles
por: Kostyushev, Dmitry, et al.
Publicado: (2020)

Previous hepatitis B viral infection–an underestimated cause of pancreatic cancer
por: Batskikh, Sergey, et al.
Publicado: (2022)

Clearing of Foreign Episomal DNA from Human Cells by CRISPRa-Mediated Activation of Cytidine Deaminases
por: Brezgin, Sergey, et al.
Publicado: (2020)

Replenishment of Hepatitis B Virus cccDNA Pool Is Restricted by Baseline Expression of Host Restriction Factors In Vitro
por: Brezgin, Sergey, et al.
Publicado: (2019)

ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage
por: Kostyusheva, Anastasiya, et al.
Publicado: (2019)

Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9
por: Kostyushev, Dmitry, et al.
Publicado: (2023)

Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus
por: Kostyushev, Dmitry, et al.
Publicado: (2023)

Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics
por: Brezgin, Sergey, et al.
Publicado: (2023)

The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases
por: Lou, Juan, et al.
Publicado: (2022)

Application of CRISPR/Cas Systems in the Nucleic Acid Detection of Infectious Diseases
por: Li, Junwei, et al.
Publicado: (2022)

Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression
por: Kolesova, Ekaterina P., et al.
Publicado: (2023)

Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens
por: GAO, Hongdan, et al.
Publicado: (2022)

Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems
por: Karpov, Dmitry S., et al.
Publicado: (2022)

Elimination of infectious HIV DNA by CRISPR–Cas9
por: Das, Atze T, et al.
Publicado: (2019)

Nanomedicine for increasing the oral bioavailability of cancer treatments
por: Parodi, Alessandro, et al.
Publicado: (2021)

CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases
por: Serajian, Sahar, et al.
Publicado: (2021)

SHERLOCK and DETECTR: CRISPR-Cas Systems as Potential Rapid Diagnostic Tools for Emerging Infectious Diseases
por: Mustafa, Mujahed I., et al.
Publicado: (2021)

Epidemiology and Genotype Distribution of Hepatitis C Virus in Russia
por: Pimenov, Nikolay, et al.
Publicado: (2022)

Widespread CRISPR repeat-like RNA regulatory elements in CRISPR-Cas systems
por: Shmakov, Sergey A., et al.
Publicado: (2023)

CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases
por: Ding, Ronghua, et al.
Publicado: (2021)

Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system
por: Zhang, Yuquan, et al.
Publicado: (2022)

Detection of Infectious Viruses Using CRISPR-Cas12-Based Assay
por: Talwar, Chandana S., et al.
Publicado: (2021)

CRISPR/Cas system for yeast genome engineering: advances and applications
por: Stovicek, Vratislav, et al.
Publicado: (2017)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

Point-of-Care Testing for Infectious Diseases Based on Class 2 CRISPR/Cas Technology
por: Chen, Shiu-Jau, et al.
Publicado: (2023)

The Use of CRISPR/Cas9 as a Tool to Study Human Infectious Viruses
por: Lin, Huafeng, et al.
Publicado: (2021)

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System
por: Qiao, Huanhuan, et al.
Publicado: (2021)

Drug Inducible CRISPR/Cas Systems
por: Zhang, Jingfang, et al.
Publicado: (2019)

Origins and evolution of CRISPR-Cas systems
por: Koonin, Eugene V., et al.
Publicado: (2019)

Therapeutic Applications of the CRISPR-Cas System
por: Kang, Kyungmin, et al.
Publicado: (2022)

Mechanisms regulating the CRISPR-Cas systems
por: Zakrzewska, Marta, et al.
Publicado: (2023)

Application of CRISPR Cas Systems for Biosensing
por: Liu, Chung Chiun, et al.
Publicado: (2023)

Hepatitis B virus markers in hepatitis B surface antigen negative patients with pancreatic cancer: Two case reports
por: Batskikh, Sergey, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g0hafgh4gv7feacpdmg87d7rdr